These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4207759)

  • 1. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.
    Wang L; Takayama K
    Antimicrob Agents Chemother; 1972 Dec; 2(6):438-41. PubMed ID: 4207759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.
    Takayama K; Wang L; David HL
    Antimicrob Agents Chemother; 1972 Jul; 2(1):29-35. PubMed ID: 4208567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra.
    Davidson LA; Takayama K
    Antimicrob Agents Chemother; 1979 Jul; 16(1):104-5. PubMed ID: 112917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis.
    Takayama K; Schnoes HK; Armstrong EL; Boyle RW
    J Lipid Res; 1975 Jul; 16(4):308-17. PubMed ID: 806645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria.
    Takayama K
    Ann N Y Acad Sci; 1974 May; 235(0):426-38. PubMed ID: 4212333
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of low temperature on growth, viability, and synthesis of mycolic acids of Mycobacterium tuberculosis strain H37Ra.
    Takayama K; Armstrong EL; Davidson LA; Kunugi KA; Kilburn JO
    Am Rev Respir Dis; 1978 Jul; 118(1):113-7. PubMed ID: 98081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
    Takayama K; Armstrong EL; David HL
    Am Rev Respir Dis; 1974 Jul; 110(1):43-8. PubMed ID: 4209359
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan uptake by Mycobacterium tuberculosis H37Rv--inhibition by isoniazid.
    Sundaram KS; Venkitasubramanian TA
    Biochem Biophys Res Commun; 1977 Sep; 78(2):839-45. PubMed ID: 410415
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.
    Quémard A; Lacave C; Lanéelle G
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1035-9. PubMed ID: 1656850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
    Banerjee A; Dubnau E; Quemard A; Balasubramanian V; Um KS; Wilson T; Collins D; de Lisle G; Jacobs WR
    Science; 1994 Jan; 263(5144):227-30. PubMed ID: 8284673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide.
    Franceschelli JJ; Belardinelli JM; Tong P; Loftus B; Recio-Balsells A; Labadié GR; Gordon SV; Morbidoni HR
    Tuberculosis (Edinb); 2018 Sep; 112():69-78. PubMed ID: 30205971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope.
    Winder FG; Collins P; Rooney SA
    Biochem J; 1970 Apr; 117(2):27P. PubMed ID: 4986870
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoniazid uptake in relation to growth inhibition of Mycobacterium tuberculosis.
    Beggs WH; Jenne JW; Hall WH
    J Bacteriol; 1968 Aug; 96(2):293-7. PubMed ID: 4970644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycolic acid index susceptibility method for Mycobacterium tuberculosis.
    Viader-Salvadó JM; Garza-González E; Valdez-Leal R; del Bosque-Moncayo MA; Tijerina-Menchaca R; Guerrero-Olazarán M
    J Clin Microbiol; 2001 Jul; 39(7):2642-5. PubMed ID: 11427584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of isoniazid killing: clarity through the scope of genetics.
    Vilchèze C; Jacobs WR
    Annu Rev Microbiol; 2007; 61():35-50. PubMed ID: 18035606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.